Analystreport

Health Catalyst, Inc. (NASDAQ: HCAT) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $62.00 to $35.00.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report